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Introduction: Simulation-based research (SBR) is rapidly expanding but the quality of
reporting needs improvement. For a reader to critically assess a study, the elements
of the study need to be clearly reported. Our objective was to develop reporting
guidelines for SBR by creating extensions to the Consolidated Standards of Reporting
Trials (CONSORT) and Strengthening the Reporting of Observational Studies in Epi-
demiology (STROBE) Statements.
Methods: An iterative multistep consensus-building process was used on the basis of
the recommended steps for developing reporting guidelines. The consensus process
involved the following: (1) developing a steering committee, (2) defining the scope of
the reporting guidelines, (3) identifying a consensus panel, (4) generating a list of items
for discussion via online premeeting survey, (5) conducting a consensus meeting, and
(6) drafting reporting guidelines with an explanation and elaboration document.
Results: The following 11 extensions were recommended for CONSORT: item 1
(title/abstract), item 2 (background), item 5 (interventions), item 6 (outcomes), item 11
(blinding), item 12 (statistical methods), item 15 (baseline data), item 17 (outcomes/
estimation), item 20 (limitations), item 21 (generalizability), and item 25 (funding).
The following 10 extensions were recommended for STROBE: item 1 (title/abstract), item
2 (background/rationale), item 7 (variables), item 8 (data sources/measurement), item
12 (statistical methods), item 14 (descriptive data), item 16 (main results), item 19
(limitations), item 21 (generalizability), and item 22 (funding). An elaboration docu-
ment was created to provide examples and explanation for each extension.
Conclusions: We have developed extensions for the CONSORT and STROBE State-
ments that can help improve the quality of reporting for SBR.
(Sim Healthcare 11:238Y248, 2016)
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Simulation has seen growing use in health care as a ‘‘tool,
device, and/or environment (that) mimics an aspect of
clinical care’’1 to improve health care provider performance,
health care processes, and ultimately patient outcomes.1Y5
The use of simulation in health care has been accompanied
by an expanding body of simulation-based research (SBR)
addressing both educational and clinical issues.6Y15 Broadly
speaking, SBR can be broken down into 2 categories: (1)
research addressing the efficacy of simulation as a training
methodology (ie, simulation-based education as the subject
of research) and (2) research using simulation as an inves-
tigative methodology (ie, simulation as the environment for
research).16,17 Many features of SBR overlap with traditional
clinical or educational research. However, the use of simu-
lation in research introduces a unique set of features that
must be considered when designing the methodology and
reported when publishing the study.16Y19
As has been shown in other fields of medicine,20
the quality of reporting in health professions education re-
search is inconsistent and sometimes poor.1,11,21Y23 Sys-
tematic reviews in medical education have quantitatively
documented missing elements in the abstracts and main
texts of published reports, with particular deficits in the
reporting of study design, definitions of independent
and dependent variables, and study limitations.21Y23 In re-
search specific to simulation for health care professions
education, a systematic review noted many studies failing
to ‘‘clearly describe the context, instructional design, or out-
comes.’’1 Another study found that only 3% of studies in-
corporating debriefing in simulation education reported
all the essential characteristics of debriefing.11 Failure to
adequately describe the key elements of a research study
impairs the efforts of editors, reviewers, and readers to
critically appraise strengths and weaknesses24,25 or apply and
replicate findings.26 As such, incomplete reporting represents
a limiting factor in the advancement of the field of simulation
in health care.
Recognition of this problem in clinical research has led
to the development of a growing number of reporting guide-
lines in medicine and other fields, including the Consolidated
Standards of Reporting Trials (CONSORT) Statement for ran-
domized trials,27Y30 the Strengthening the Reporting of Ob-
servational Studies in Epidemiology (STROBE) Statement for
observational studies,31,32 and the Preferred Reporting Items
for Systematic Review and Meta-Analyses Statement,33Y35
among more than 250 others.36 Transparent reporting of re-
search allows readers to clearly identify and understand ‘‘what
was planned, what was done, what was found, and what
conclusions were drawn.’’31 In addition to these statements,
experts have encouraged37 and published extensions to
existing statements that focus on specific methodological
approaches38,39 or clinical fields.40,41 In this study, we aimed
to develop reporting guidelines for SBR by creating extensions
to the CONSORT Statement and the STROBE Statement
specific to the use of simulation in health care research. These
reporting guidelines are meant to be used by authors sub-
mitting manuscripts involving SBR and to assist editors and
journal reviewers when assessing the suitability of simulation-
based studies for publication.
METHODS
The study protocol was reviewed by Yale University Bio-
medical Institutional Review Board and was granted exempt
status. We conducted a multistep consensus process on the
basis of previously described steps for developing health
research reporting guidelines.42 These steps involved the fol-
lowing: (1) developing a steering committee, (2) defining the
scope of the reporting guidelines, (3) identifying a consensus
panel, (4) generating a list of items for discussion, (5) conducting
a consensus meeting, and (6) drafting reporting guidelines
and an explanation and elaboration document.
Development of the Steering Committee
A steering committee was formed consisting of 12 mem-
bers with expertise in simulation-based education and re-
search, medical education research, study design, statistics,
epidemiology, and clinical medicine. The steering com-
mittee defined the scope of the reporting guidelines, iden-
tified participants for the consensus process, generated a
premeeting survey, planned and conducted the consensus
meeting, and ultimately drafted and refined the final version
of the reporting guidelines and the explanation and elabo-
ration document.
Defining the Scope of the Reporting Guidelines
To clarify the scope of the reporting guideline exten-
sions, we defined simulation as encompassing a diverse range
of products including computer-based virtual reality simu-
lators, high-fidelity and static mannequins, plastic models
and task trainers, live animals, inert animal products, human
cadavers, and standardizedor simulatedpatients (ie, individuals
trained to portray a patient). Our definition excluded research
using computational simulation and mathematical modeling,
because the guidelinesweredeveloped for researchusinghuman
participants, either as learners or health care providers.1 The
steering committee determined to create reporting guidelines
encompassing the following 2 categories of SBR: (1) studies
evaluating simulation for educational use and (2) studies using
simulation as investigative methodology.16 We identified the
CONSORT28 and STROBE31,32 Statements as reflecting the
current reporting standards in health care research and aimed
to develop extensions of these 2 statements for quantitative
SBR. The CONSORT Statement and extensions were devel-
oped for randomized trials, and the STROBE Statement and
extensions were developed for observational studies (cohort,
case-control, and cross-sectional studydesigns).Our guideline
extensions are not intended for qualitative research, mixed-
methods research, or validation studies.
Identification of Consensus Panel Participants
The steering committee aimed to identify a consensus
group with a broad range of expertise in SBR, including
experience in conducting single and multicenter simulation-
based studies, expertise in educational research, statistics, clin-
ical epidemiology, and research methodology, and with varying
clinical backgrounds. We invited the editor-in-chief and edi-
torial board members of the following 3 health care simu-
lation journals: Simulation in Healthcare, BMJ Simulation
and Technology-Enhanced Learning, and Clinical Simulation
in Nursing, and editorial board members from the following
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2medical education journals:Medical Education andAdvances
in Health Sciences Education. In total, 60 expert participants
were invited to complete the online survey.
Generating a List of Items for Discussion
Before the consensus meeting, we surveyed the expert
participants via apremeeting survey (www.surveymonkey.com)
to identify items in the CONSORT and STROBE Statements
that required an extension for SBR. The survey included all
items from both the CONSORTand STROBE Statements and
was pilot tested among steering committee members before
being posted online. Participants were asked to provide sug-
gested wording for the items they identified as requiring an
extension. Participants were also given the option of sug-
gesting new simulation-specific items for both the CONSORT
and STROBE Statements. On the basis of methods previously
used to develop extensions to the CONSORT Statement,40 we
used a cutoff of endorsementby at least one thirdof respondents
to identify high priority items for discussion during the con-
sensus meeting.
Consensus Meeting
A 5-hour consensus conference was conducted in January
2015 in New Orleans, during the annual International Net-
work for Simulation-Based Pediatric Innovation, Research
and Education (INSPIRE) meeting. The initial 60 consensus
panel participants were invited to attend the consensus con-
ference as well as INSPIRE network members (ie, clinicians,
researchers, educators, psychologists, statisticians, and epi-
demiologists). The INSPIRE network is the world’s largest
health care simulation research network with a proven track
record of conducting rigorous simulation-based studies in
health care.43Y50
The results of the online survey were circulated to each
member of the steering committee, who were then assigned
to review specific items from the CONSORT and STROBE
statements on the basis of their expertise. The consensus
meeting started with a brief didactic presentation reviewing
the CONSORT and STROBE Statements, followed by a de-
scription of the study objectives and consensus process. In
small groups, each steering committee member led a dis-
cussion with 4 or 5 individuals tasked with determining
whether a simulation-specific extension was required for
their assigned items and if so to recommend wording for the
extension. Consensus panel participants were evenly dis-
tributed among small groups and specifically assigned to
review items on the basis of their area of expertise. High
priority items were discussed at length, but all other checklist
items were also discussed in the small groups.
After small groupdiscussion, the recommended simulation-
specific extensions for both the CONSORT and STROBE State-
ments were presented to the entire group of participants. Each
proposed extension was discussed before recommended word-
ing was established. Minutes from the small and large group
discussions were used to inform the development of the expla-
nation and elaboration document.42
Drafting Reporting Guidelines
The proposed extensions were circulated for com-
ment among all meeting participants and consensus panel
participants who could not attend the meeting. The steering
committee used the comments to further refine the exten-
sion items. To evaluate these items in practice, 4 members
of the steering committee independently pilot tested both
the CONSORT and STROBE Statements with simulation-
specific extensions. They used 2 published SBR studies (ie,
one for each type of SBR), while ensuring that 1 study was
a randomized trial and the other an observational study.
Feedback from pilot testing informed further revisions. The
final reporting guidelines with extensions were circulated
to the steering committee 1 last time to ensure the final
product accurately represented discussion during and after
the consensus conference. An explanation and elaboration
document was developed by the steering committee to
provide further detail for each item requiring a simulation-
specific extension.42
RESULTS
Premeeting Survey
There was a 75% response rate for the survey, with 45 of
the 60 participants completing the entire survey. An addi-
tional 12 other participants (20%) partially completed the
survey. Of the 57 participants who responded to the survey,
17 were medical journal editors or editorial board members,
24 had advanced degrees (Masters, PhD), 16 with advanced
degrees in medical education or educational psychology,
6 were nurses, 1 was a psychologist, and 54 were physicians
(representing anesthesiology, critical care, emergency medi-
cine, pediatrics, and surgery). Of the 3 participants who did
not complete the survey, 2 were physicians and 1 was a sci-
entist. The results of the survey are described in Supplemental
Digital Content 1 (See Table, http://links.lww.com/SIH/A265,
Supplemental Digital Content 1, Survey Responses).
Consensus Meeting
In total, 35 consensus panel participants who com-
pleted the premeeting survey attended the consensus con-
ference. An additional 30 attendees were INSPIRE network
members. Of the 65 total attendees at the consensus con-
ference, 12 were medical journal editors or editorial board
members, 18 had advanced degrees (Masters, PhD), 4 were
nurses, 1was apsychologist, and60werephysicians (representing
anesthesiology, critical care, emergency medicine, pediatrics,
and surgery).
The following 11 simulation-specific extensions were
recommended for the CONSORT Statement: item 1 (title
and abstract), item 2 (background), item 5 (interventions),
item 6 (outcomes), item 11 (blinding), item 12 (statistical
methods), item 15 (baseline data), item 17 (outcomes and
estimation), item 20 (limitations), item 21 (generalizability),
and item 25 (funding). Participants agreed on the importance
of describing the rationale for and design of the simulation-
based intervention. Because many simulation-based studies
use assessment tools as an outcome measure, participants
thought that it was important to report the unit of analysis and
evidence supporting the validity and reliabilityof the assessment
tool(s) when available. In the discussion section, participants
thought that it was important to describe the limitations of SBR
and the generalizability of the simulation-based outcomes to
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TABLE 1. Simulation-Based Research Extensions for the CONSORT Statement
Item Item Number
CONSORT Description (Randomized,
Controlled Trials) Extension for SBR
Title and abstract 1 a. Identification as a randomized trial in
the title
b. Structured summary of trial design,
methods, results, and conclusions
In abstract or key terms, the MESH or
searchable keyword term must have the
word ‘‘simulation’’ or ‘‘simulated.’’
Introduction
Background 2 a. Scientific background and explanation
of rationale
b. Specific objectives or hypotheses
Clarify whether simulation is subject of
research or investigational method
for research.
Methods
Trial design 3 a. Description of trial design (such as parallel,
factorial) including allocation ratio
b. Important changes to methods after
trial commencement (such as eligibility
criteria), with reasons
Participants 4 a. Eligibility criteria for participants
b. Settings and locations where the data
were collected
Interventions 5 The interventions for each group with
sufficient details to allow for replication,
including how and when they were actually
administered.
Describe the theoretical and/or conceptual
rationale for the design of each intervention.
Clearly describe all simulation-specific exposures,
potential confounders, and effect modifiers.
Outcomes 6 a. Completely defined prespecified primary
and secondary outcome measures, including
how and when they were assessed 6
b. Any changes to trial outcomes after the
trial commenced, with reasons
In describing the details of methods of
assessment, include (when applicable)
the setting, instrument, simulator type,
timing in relation to the intervention,
along with any methods used to enhance
the quality of measurements.
Provide evidence to support the validity and
reliability of assessment tools in this
context (if available).
Sample size/study size 7 a. How sample size was determined
b. When applicable, explanation of any
interim analyses and stopping guidelines
Randomization: sequence
generation
8 a. Method used to generate the random
allocation sequence
b. Type of randomization and details of any
restriction (such as blocking and block size)
Randomization: allocation
concealment mechanism
9 Mechanism used to implement the random
allocation sequence (such as sequentially
numbered containers), describing any steps
taken to conceal the sequence until
interventions were assigned
Randomization: implementation 10 Who generated the random allocation sequence,
who enrolled participants, and who assigned
participants to interventions
Blinding (masking) 11 a. If done, who was blinded after assignments
to interventions (eg, participants, care
providers, those assessing outcomes) and how
b. If relevant, description of the similarity of
interventions
Describe strategies to decrease risk of bias,
when blinding is not possible.
Statistical methods 12 a. Statistical methods used to compare groups
for primary and secondary outcomes
b. Methods for additional analyses, such as
subgroup analyses and adjusted analyses
Clearly indicate the unit of analysis (eg,
individual, team, system), identify
repeated measures on subjects, and
describe how these issues were addressed.
Results
Participant flow (a diagram
is strongly recommended)
13 a. For each group, the numbers of participants
who were randomly assigned, received
intended treatment, and were analyzed for
the primary outcome
b. For each group, losses and exclusions after
randomization, together with reasons
Recruitment 14 a. Dates defining the periods of recruitment
and follow-up
b. Why the trial ended or was stopped
Baseline data 15 A table showing baseline demographic and
clinical characteristics of each group
In describing characteristics of study
participants, include their previous
experience with simulation and other
relevant features as related to the
intervention(s).
(continued on next page)
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clinical outcomes (when applicable). Participants also agreed
that it was important to identify the simulator brand used in
the study and if conflict of interest for intellectual property
existed among investigators. The group did not feel that
modifications to the CONSORTflow diagramwere required
for SBR. See Table 1 for CONSORT extensions for SBR.
The following 10 extensions were drafted for the STROBE
Statement: item 1 (title and abstract), item 2 (background/
rationale), item7(variables), item8(data sources/measurement),
item 12 (statistical methods), item 14 (descriptive data),
item 16 (main results), item 19 (limitations), item 21
(generalizability), and item 22 (funding). A similar emphasis
was placed on the importance of describing all simulation-
specific exposures, confounders, and effect modifiers, as was
discussed for the CONSORT. Other extensions for the
STROBE were under similar categories as the proposed ex-
tensions for the CONSORT. See Table 2 for STROBE exten-
sions for SBR.
For both the CONSORT and STROBE Statements, ex-
tensive discussion occurred in the consensus meeting related
to the educational intervention and controlling for simulation-
specific variables that pose as potential threats to the internal
validity of simulation studies. A group of consensus panel par-
ticipants with expertise in simulation-based education and in-
structional design used their knowledge of educational theory,
existing educational research guidelines,51 and systematic reviews
of SBR1,5Y8,11 to address this issue (Table 3). Table 3 offers an
additional checklist of key elements specific to SBR, for item 5
(interventions) on the CONSORT Statement and item 7
(variables) on the STROBE Statement, that should be reported
for all simulation studies, for both the intervention and control
groups (if applicable).
In modeling the explanation and elaboration document
after other similar documents published in conjunction with
reporting guidelines,28,32 we provide a specific example for
each item requiring a new extension coupled with the
background and rationale for including that information for
that item. We encourage readers to refer to the explanation
and elaboration document to seek further detail about the
nature and type of recommended reporting for each new
extension (see text, http://links.lww.com/SIH/A266, Sup-
plemental Digital Content 2, Explanation and Elaboration of
the Simulation-Specific Extensions for the CONSORT and
STROBE Statements).
DISCUSSION
We have developed reporting guidelines for SBR by cre-
ating extensions to both the CONSORT28 and STROBE31
Statements. These new extensions were developed via a
consensus-building process with multiple iterative steps
involving an international group of experts with diverse
TABLE 1. (Continued)
Item Item Number
CONSORT Description (Randomized,
Controlled Trials) Extension for SBR
Numbers analyzed 16 For each group, number of participants
(denominator) included in each analysis and
whether analysis was by original assigned groups
Outcomes and estimation 17 a. For each primary and secondary outcome,
results for each group, and the estimated effect
size and its precision (such as 95% confidence
interval)
b. For binary outcomes, presentation of both
absolute and relative effect sizes is recommended
For assessments involving 91 rater,
interrater reliability should be reported.
Ancillary analyses 18 Results of any other analyses performed, including
subgroup analyses and adjusted analyses,
distinguishing prespecified from exploratory
Adverse events 19 All important harms or unintended effects in
each group (for specific guidance, see CONSORT
for harms)
Discussion
Limitations 20 Trial limitations, addressing sources of potential
bias, imprecision, and, if relevant, multiplicity
of analyses
Specifically discuss the limitations of SBR.
Generalizability 21 Generalizability (external validity, applicability)
of the trial findings
Describe generalizability of simulation-based
outcomes to patient-based outcomes
(if applicable).
Interpretation 22 Interpretation consistent with results, balancing
benefits and harms, and considering other
relevant evidence
Other information
Registration 23 Registration number and name of trial registry
Protocol 24 Where the full trial protocol can be accessed,
if available
Funding 25 Sources of funding and other support (such as
supply of drugs), role of funders
List simulator brand and if conflict of
interest for intellectual property exists.
MESH, Medical Subject Headings.
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TABLE 2. Simulation-Based Research Extensions for the STROBE Statement
Item ItemNumber STROBE Description (Observational Studies) Extension for SBR
Title and abstract 1 a. Indicate the study’s design with a commonly
used term in the title or the abstract.
b. Provide in the abstract an informative and balanced
summary of what was done and what was found.
In abstract or key terms, the MESH or searchable
keyword term must have the word simulation
or simulated.
Introduction
Background/rationale 2 Explain the scientific background and rationale
for the investigation being reported.
Clarify whether simulation is subject of research
or investigational method for research.
Objectives 3 State specific objectives, including any
prespecified hypotheses.
Methods
Study design 4 Present key elements of study design early
in the paper.
Setting 5 Describe the setting, locations, and relevant
dates, including periods of recruitment,
exposure, follow-up, and data collection.
Participants 6 a. Cohort study: give the eligibility criteria and
the sources and methods of selection of
participants. Describe methods of follow-up.
Case-control study: give the eligibility criteria
and the sources and methods of case
ascertainment and control selection. Give the
rationale for the choice of cases and controls.
Cross-sectional study: give the eligibility
criteria and the sources and methods of
selection of participants.
b. Cohort study: for matched studies, give matching
criteria and number of exposed and unexposed.
Case-control study: for matched studies, give
matching criteria and the number of controls
per case.
Variables 7 Clearly define all outcomes, exposures, predictors,
potential confounders, and effect modifiers.
Give diagnostic criteria, if applicable.
Describe the theoretical and/or conceptual
rationale for the design of the intervention/exposure.
Describe the intervention/exposure with sufficient
detail to permit replication.
Clearly describe all simulation-specific exposures,
potential confounders, and effect modifiers.
Data sources/measurement 8 For each variable of interest, give sources of data
and details of methods of assessment
(measurement).
Describe comparability of assessment methods
if there is 91 group.
In describing the details of methods of assessment,
include (when applicable) the setting, instrument,
simulator type, timing in relation to the
intervention, along with any methods used to
enhance the quality of measurements.
Provide evidence to support the validity and
reliability of assessment tools in this context
(if available).
Bias 9 Describe any efforts to address potential
sources of bias.
Study size 10 Explain how the study size was arrived.
Quantitative variables 11 Explain how quantitative variables were
handled in the analyses. If applicable,
describe which groupings were chosen and why.
Statistical methods 12 a. Describe all statistical methods, including those
used to control for confounding.
b. Describe any methods used to examine subgroups
and interactions.
c. Explain how missing data were addressed.
d. Cohort study: if applicable, explain how loss
to follow-up was addressed.
Case-control study: if applicable, explain how
matching of cases and controls was addressed.
Cross-sectional study: if applicable, describe analytical
methods taking account of sampling strategy.
e. Describe any sensitivity analyses.
Clearly indicate the unit of analysis (eg,
individual, team, system), identify repeated
measures on subjects, and describe how these
issues were addressed.
Results
Participants 13 a. Report the numbers of individuals at each stage
of the study (eg, numbers potentially eligible,
examined for eligibility, confirmed eligible,
included in the study, completing follow-up,
and analyzed).
b. Give reasons for nonparticipation at each stage.
c. Consider use of a flow diagram.
(continued on next page)
Vol. 11, Number 4, August 2016 * 2016 by Society for Simulation in Healthcare. 243
Copyright © 2016 by the Society for Simulation in Healthcare. Unauthorized reproduction of this article is prohibited.
backgrounds and expertise. By creating extensions to both the
CONSORT and STROBE Statements that can be applied to
studies in both categories of SBR, we have developed reporting
guidelines that are applicable to most studies involving sim-
ulation in health care research. To further assist authors in
reporting SBR studies, we have published an explanation and
elaboration document as an appendix that provides specific
examples and details for all the new simulation-specific ex-
tensions for both the CONSORT and STROBE Statements.
The CONSORT and STROBE Statements with accom-
panying SBR extensions are meant to serve as a guide to
reporting. As with other CONSORT and STROBE State-
ments, the items are not meant to ‘‘prescribe the reportingI
in a rigid format,’’ but rather the ‘‘order and format for
presenting information depend on author preferences, journal
style, and the traditions of the research field.’’28,31 We
encourage authors to refer to the explanation and elaboration
document that provides details regarding specific elements
related to individual items that should be reported for SBR.
The use of reporting guidelines can have positive effects on
various health care simulation stakeholders, including funders
of SBR and those applying for funding (ie, use as a template for
grant applications), educators (ie, use as a training tool), and
students (ie, use to develop protocols for coursework or
research).33 The application of these reporting guidelines
will help enhance quality of reporting for quantitative SBR
and assist journal reviewers and editors when faced with
assessing the strengths and weaknesses of simulation-based
studies in health care.24,52,53 We encourage journals pub-
lishing SBR to consider endorsing the simulation-specific
extensions for the CONSORT and STROBE Statements and
adding these to their ‘‘instructions for authors.’’
TABLE 2. (Continued)
Item ItemNumber STROBE Description (Observational Studies) Extension for SBR
Descriptive data 14 a. Give characteristics of study participants
(eg, demographic, clinical, social) and
information on exposures and potential
confounders.
b. Indicate the number of participants with
missing data for each variable of interest.
c. Cohort study: summarize follow-up time
(eg, average and total amount).
In describing characteristics of study participants,
include their previous experience with
simulation and other relevant features as related
to the intervention(s).
Outcome data 15 Cohort study: report numbers of outcome
events or summary measures over time.
Case-control study: report numbers in each
exposure category or summary measures
of exposure.
Cross-sectional study: report numbers of
outcome events or summary measures.
Main results 16 a. Give unadjusted estimates and, if applicable,
confounder-adjusted estimates and their
precision (eg, 95% confidence intervals).
Make clear which confounders were adjusted
for and why they were included.
b. Report category boundaries when continuous
variables were categorized.
c. If relevant, consider translating estimates of
relative risk into absolute risk for a meaningful
time period.
For assessments involving 91 rater, interrater
reliability should be reported.
Other analyses 17 Report other analyses done (eg, analyses of
subgroups and interactions and sensitivity
analyses).
Discussion
Key results 18 Summarize key results with reference to
study objectives.
Limitations 19 Discuss limitations of the study, taking into
account sources of potential bias or
imprecision. Discuss both direction and
magnitude of any potential bias.
Specifically discuss the limitations of SBR.
Interpretation 20 Give a cautious overall interpretation of
results considering objectives, limitations,
multiplicity of analyses, results from similar
studies, and other relevant evidence.
Generalizability 21 Discuss the generalizability (external validity)
of the study results.
Describe generalizability of simulation-based
outcomes to patient-based outcomes
(if applicable).
Other information
Funding 22 Give the source of funding and the role of the
funders for the present study and, if applicable,
for the original study on which the present
article is based.
List simulator brand and if conflict of interest
for intellectual property exists.
MESH, Medical Subject Headings.
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Simulation-based research has several unique factors
that prompted us to develop simulation-specific extensions
for both the CONSORTand STROBE Statements. First, there
are a wide variety of simulators and simulation modalities
available for use in research.16 This, coupled with a plethora
of instructional design features in simulation-based educa-
tional research, makes describing the simulation interven-
tion a critically important component of any educational
study involving simulation (Table 3).6,8,19 Second, SBR pro-
vides opportunity for the investigator to standardize the
TABLE 3. Key Elements to Report for Simulation-Based Research
Elements* Subelements† Descriptor
Participant orientation Orientation to the simulator Describe how participants were oriented to the simulator (eg, method, content,
duration).
Orientation to the environment Describe how participants were oriented to the environment (eg, method,
content, duration).
Simulator type16 Simulator make and model Describe the simulator make and model.
Simulator functionality Describe functionality and/or technical specifications that are relevant to the
research question. Describe modifications, if any. Describe limitations of
the simulator.
Simulation environment16 Location Describe where the simulation was conducted (eg, in situ clinical environment,
simulation center, etc).
Equipment Describe the nature of the equipment available (eg, type, amount, location, size, etc).
External stimuli Describe any external stimuli (eg, background noise).
Simulation event/scenario16 Event description Describe if the event was programmed and/or scripted (eg, orientation to event,
scenario progression, triggers). If a scenario was used, the scenario script
should be provided as an appendix.
Learning objectives List the learning objectives and describe how they were incorporated into
the event.
Group vs. individual practice Describe if the simulation was conducted in groups or as individuals.
Use of adjuncts Describe if adjuncts (eg, moulage, media, props) were used.
Facilitator/operator characteristics Describe experience (eg, clinical, educational), training (eg, fellowship, courses),
profession.
Pilot testing Describe if pilot testing was conducted (eg, number, duration, frequency).
Actors/confederates/standardized/
simulated patients16
Describe experience (eg, clinical, educational), training (eg, fellowship,
courses), profession, sex. Describe various roles, including training,
scripting, orientation, and compliance with roles.
Instructional design (for educational
interventions)53 or exposure
(for simulation as investigative
methodology)16
Duration Describe the duration of the educational intervention. If the intervention
involves more than one segment, describe the duration of each segment.
Timing Describe the timing of the educational intervention relative to the time when
assessment/data collection occurs (eg, just-in-time training).
Frequency/repetitions Describe how many repetitions were permitted and/or the frequency of training
(eg, deliberate practice).
Clinical variation Describe the variation in clinical context (eg, multiple different patient scenarios).
Standards/assessment Describe predefined standards for participant performance
(eg, mastery learning) and how these standards were established.
Adaptability of intervention Describe how the training was responsive to individual learner needs
(eg, individualized learning).
Range of difficulty Describe the variation in difficulty or complexity of the task.
Nonsimulation interventions
and adjuncts
Describe all other nonsimulation interventions (eg, lecture, small group
discussion) or educational adjuncts (eg, educational video), how they were
used, and when they were used relative to the simulation intervention.
Integration Describe how the intervention was integrated into curriculum.
Feedback and/or debriefing11 Source Describe the source of feedback (eg, computer, simulator, facilitator).
Duration Describe the amount of time spent.
Facilitator presence Describe if a facilitator was present (yes/no), and if so, how many facilitators.
Facilitator characteristics Describe experience (eg, clinical, educational), training (eg, fellowship, courses),
profession, sex.
Content Describe content (eg, teamwork, clinical, technical skills, and/or inclusion of
quantitative data, etc).
Structure/method Describe the method of debriefing/feedback and debriefing framework used
(ie, phases).
Timing Describe when the feedback and/or debriefing was conducted relative to the
simulation event (eg, terminal vs. concurrent).
Video Describe if video was used (yes/no) and how it was used.
Scripting Describe if a script was used (yes/no) and provide script details as an appendix.
*These elements may apply for the simulation intervention (eg, randomized controlled trial or observational study with simulation as an educational intervention) or when
simulation is the environment for research (eg, randomized controlled trial or observational study using simulation as an investigative methodology). Elements should be described
in sufficient detail to permit replication.
†Description is required only if applicable.
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simulated environment and/or simulated patient condition.
Standardization of the environment and patient condition
allows the investigator to account for many of the potential
threats to internal validity that are associated with simulation.
Clear reporting of standardization strategies helps the reader
understandhow the independentvariablewas isolated(Table3).16
Third, many simulation studies involve capturing outcomes
from a variety of data sources (eg, observation, video review,
simulator data capture). When assessment instruments are
used (eg, expert raters assessing performance), it is imperative
to discuss the psychometric properties of these instruments.5
Existing guidelines fall short in this regard, and these new
guidelines help address this issue. Lastly, simulation-based
studies assessing outcomes in the simulated environment on-
ly (eg, clinical performance) should attempt to provide evi-
dence to support how thefindings in the simulated environment
translate to a valid representation of performance in the real
clinical environment.3 By doing so, authors help convey the
relevance and importance of their findings.
Limitations
Our consensus process has several limitations. Although
we had a 75% response rate for our survey, an additional
20% of participants only partially completed the survey. This
may have potentially introduced a selection bias, although
the survey represented only 1 step in our consensus-building
process. We include a wide variety of experts in our con-
sensus meeting, but many of them had a pediatric clinical
background. We minimized this potential bias by ensuring
that each breakout group had at least 1 expert participant with
a background outside of pediatrics. Furthermore, the princi-
ples of SBRare commonacross specialties andprofessions, and
INSPIRE network members represent researchers who are
recognized internationally for being leaders in SBR. We
based our reporting guidelines on the CONSORT and
STROBE guidelines developed by clinical researchers. Other
guidelines could have been used as a starting point such as
the American Education Research Association standards
developed in 2006.54 Our logic was to start with reporting
guidelines that were applicable to all types of research, thus
providing us more flexibility in generating extensions for
both types of SBR. Cross-checking against the American
Education Research Association guideline does not reveal
areas that we might have missed.55 Although we tried to de-
velop reporting guidelines for all types of SBR, we recognize
that there may be specific types of research that may re-
quire new items or different extensions. For example, studies
designed to evaluate the validity of simulation-based assess-
ments vary in their reporting requirements. The Standards
for Reporting of Diagnostic Accuracy Statement55 addresses
these points, and a recent review operationalized these
standards and applied them to SBR.56 Other reporting guide-
lines that might be amenable for simulation-specific extensions
include the Consolidated Criteria for Reporting Qualita-
tive Research,57 and the Standards for Quality Improvement
Reporting Excellence58 guidelines for reporting quality
improvement studies. Because the field of SBR grows,
the simulation-specific extensions for the CONSORT and
STROBE Statements may need to be revised or refined. We
encourage authors, reviewers, and editors to visit ourWeb site
(http://inspiresim.com/simreporting/) and provide feedback
that will be used to inform subsequent revisions to these
reporting guidelines.
CONCLUSIONS
The unique features of SBR highlight the importance of
clear and concise reporting that helps readers understand
how simulation was used in the research. Poor and incon-
sistent reporting makes it difficult for readers to interpret
results and replicate interventions and hence less likely for
research to inform change that will positively influence patient
outcomes. The use of standardized reporting guidelines will
serve as a guide for authors wishing to submit manuscripts
for publication, and in doing so, it draws attention to the
important elements of SBR and ultimately improves the
quality of simulation studies conducted in the future.
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